DKK1 and breast cancer: Yue et al.177 revealed that RSPO2 and RANKL upregulated the expression of the secretory protein DKK-1 by binding to LGR4 receptors on the surface of breast cancer cells and activating the β-Catenin/Gαq signaling pathway.